Document is current
Any future updates will be listed below
-
Authors
Roscioli, Emanuele https://orcid.org/0000-0003-4125-4632
Zucconi Galli Fonseca, Vittoria https://orcid.org/0000-0002-4593-2544
Bosch, Soraya Soledad https://orcid.org/0000-0003-1459-4463
Paciello, Ida
Maccari, Giuseppe
Cardinali, Giulia
Batani, Giampiero
Stazzoni, Samuele https://orcid.org/0000-0002-1579-6895
Tiseo, Giusy
Giordano, Cesira
Yuwei, Shen
Capoccia, Laura https://orcid.org/0009-0001-4172-1117
Cardamone, Dario
Ridelfi, Matteo
Troisi, Marco
Manganaro, Noemi https://orcid.org/0000-0001-8512-4704
Mugnaini, Chiara
De Santi, Concetta
Ciabattini, Annalisa https://orcid.org/0000-0002-4585-7783
Cerofolini, Linda
Fragai, Marco
Licastro, Danilo
Wyres, Kelly https://orcid.org/0000-0002-4033-6639
Dortet, Laurent https://orcid.org/0000-0001-6596-7384
Barnini, Simona
Nicolau, David P.
Menichetti, Francesco
Falcone, Marco
Abdelraouf, Kamilia https://orcid.org/0000-0003-2524-352X
Sala, Claudia
Kabanova, Anna https://orcid.org/0000-0002-2077-472X
Rappuoli, Rino https://orcid.org/0000-0002-8827-254X
- License Information
-
More Information
Article History
Received: 24 June 2024
Accepted: 8 July 2025
First Online: 1 October 2025
Competing interests
: Patent application 102023000000924 describing isolated mAbs has been filed by Fondazione Toscana Life Sciences. E.R., V.Z.G.F., S.S.B., I.P., G.B., D.C., G.M., A.K. and C.S. are listed as inventors and declare no competing financial interests. R.R. holds shares in the GSK group of companies and declares no other financial or non-financial relationships and activities. The other authors declare no competing interests.
